Aficamten vs HRS-1893
Same mechanism, same race: design-graded trial evidence for both assets, with the grading rationale shown. Grades describe the quality of the evidence, never the merits of either security.
Hypertrophic Cardiomyopathy
Shared mechanism: Cardiac myosin (inhibitor) · full Hypertrophic Cardiomyopathy pipeline
Aficamten · Myqorzo
Marketed by Cytokinetics and partners
NCT05767346 · Phase 3 · completed
This randomized, triple-blind, active-controlled Phase 3 trial (n=175) compared aficamten with the beta-blocker metoprolol succinate in adults with symptomatic obstructive hypertrophic cardiomyopathy. The primary endpoint, change in peak oxygen uptake on exercise testing at 24 weeks, improved significantly more with aficamten than metoprolol (mean difference 2.30 mL/kg/min, p<0.0001).
Next expected readout: December 2026 · NCT07600177 (registry estimate)
Reported efficacy
Change in Peak Oxygen Uptake (pVO2) by Cardiopulmonary Exercise Testing (CPET) (Baseline to Week 24): Change in Peak Oxygen Uptake (pVO2) by Cardiopulmonary Exercise Testing (CPET) (Baseline to Week 24): Aficamten 1.07 mL/kg/min (Standard Deviation 2.767) | Metoprolol -1.24 mL/kg/min (Standard Deviation 2.186) (met)
Result source: NCT05767346
HRS-1893
Developed by Jiangsu Hengrui Pharmaceuticals
No graded featured trial for this indication yet; the grade above reflects that absence, not a judgment.
Next expected readout: December 2027 · NCT07021963 (registry estimate)
No aligned efficacy figure on record for this race.
Results for Hypertrophic Cardiomyopathy
There are not yet structured results for two selected drugs in this indication. Available results are listed below instead of an empty comparison table.
HRS-1893: no structured comparison results are available for Hypertrophic Cardiomyopathy.
Reviewed results are available, but are not yet structured for this comparison. These sourced summaries are shown separately from the aligned rows.
The full competitive landscape for each asset (every same-race competitor with aligned evidence, sortable) is on the asset pages: Aficamten's landscape · HRS-1893's landscape